Posts in tag

Global Blood Therapeutics Inc


Nutanix: “You’re going to need a long-time horizon for that because they missed their quarter very, very badly, and it’s not like this is a situation like as a DexCom or something where there’s use for the product no matter what. I just think DexCom is an example of a stock that holds up rather well.” Franco-Nevada: …